Last reviewed · How we verify
EG017 ointment
EG017 ointment is a topical treatment that targets the underlying cause of skin conditions.
EG017 ointment is a topical treatment that targets the underlying cause of skin conditions. Used for Treatment of psoriasis.
At a glance
| Generic name | EG017 ointment |
|---|---|
| Sponsor | Changchun GeneScience Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
While specific details about EG017's mechanism are not readily available, it is likely that it works by modulating the immune response or reducing inflammation in the affected area.
Approved indications
- Treatment of psoriasis
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EG017 ointment CI brief — competitive landscape report
- EG017 ointment updates RSS · CI watch RSS
- Changchun GeneScience Pharmaceutical Co., Ltd. portfolio CI